Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Orchestrating Diabetic Wound Healing by a Sunlight-Activated AIEgen-Selenide Nanospray: From Infection Control to Tissue Regeneration.

Created on 25 Jun 2026

Authors

Anum Kayani, Arsalan Raza, Qinghao Zhou, Cheng Li, Zhidong Wang, Khurshed Bozorov, Yuanyuan Ji, Feng Wang, Zhishen Ge

Published in

ACS applied materials & interfaces. Jun 25, 2026. Epub Jun 25, 2026.

Abstract

Diabetic wounds, particularly diabetic ulcers (DUs), are life-threatening complications driven by bacterial infection, persistent inflammation, oxidative stress, and a dysfunctional immune microenvironment. Addressing these interconnected barriers requires a therapeutic strategy capable of coordinating infection control with tissue repair. Here, we report a sunlight-activated nanospray formulation (C@PSe) based on a covalently engineered aggregation-induced emission luminogen (AIEgen)-selenide triblock copolymer micelle that encapsulates curcumin (Cur). This system integrates three complementary functions into a single micellar platform. The AIEgen enables on-demand antimicrobial photodynamic therapy (aPDT) under natural sunlight, achieving precise bacterial elimination. The selenide block exerts glutathione peroxidase (GPx)-like activity to scavenge excess reactive oxygen species (ROS), alleviating oxidative stress and modulating the nuclear factor kappa-B (NF-κB)-associated inflammatory signaling. Simultaneously, Cur promotes anti-inflammatory macrophage polarization and drives pro-angiogenic signaling to support tissue regeneration. In a Staphylococcus aureus-infected diabetic mouse model, C@PSe effectively resolved bacterial infection, reduced ROS-driven inflammation, and accelerated wound closure with full re-epithelialization and enhanced neovascularization. By integrating sequential antibacterial, antioxidant, and regenerative actions within a single, patient-friendly nanospray that operates under sunlight, this platform overcomes key limitations of conventional photodynamic therapy (PDT) and offers a comprehensive strategy for treating chronic diabetic wounds.

PMID:
42347974
Bibliographic data and abstract were imported from PubMed on 25 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement